Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives

By Crystal Lubbe

December 12, 2024

The article from the Africa CDC website, titled “Egypt’s Hepatitis Programme Becomes a Model for African Countries,” highlights Egypt’s successful hepatitis C elimination program, which serves as a benchmark for other African countries. By implementing the “100 Million Healthier Lives” campaign, Egypt has achieved Gold-tier certification for its progress toward eliminating hepatitis C, as recognised by the World Health Organization (WHO). This remarkable achievement showcases how effective public health initiatives can lead to significant health improvements across the continent.

Egypt’s Hepatitis C Elimination Program

Egypt Hepatitis C Program has benefited its citizens and set a powerful example for other African nations. Notably, the country has made significant strides in training and capacity building.

Training and Capacity Building

The Africa CDC, in collaboration with Egypt’s Ministry of Health and Population, has implemented training programs for experts from various African Union member states. These programs are designed to equip participants with the necessary skills to launch “screen-and-treat” programs for hepatitis C. To date, 26 members have been trained, with an additional cohort of 31 participants from multiple African countries completing their training in November 2024.

Regional Collaboration and Support

Moreover, Egypt plays a pivotal role by providing technical support, screening software, and free treatment for one million people in 14 African nations. This collaborative effort aligns with WHO screening and treatment guidelines.

Best Practices and Challenges

The training includes lectures, field trips, and discussions on best practices and challenges in hepatitis elimination. Participants visit hospitals, healthcare settings, and pharmaceutical companies to understand Egypt’s comprehensive strategy.

Africa CDC’s Role

The Africa CDC is actively supporting African nations by funding seroprevalence surveys, providing necessary kits and drugs, and training health workers. For example, Madagascar is currently undergoing a capacity and readiness assessment for viral hepatitis elimination, as part of the support provided by the Africa CDC.

South-South Cooperation

The initiative promotes South-South cooperation, encouraging shared learning and collaboration to improve public health outcomes continent-wide. This approach is a cornerstone of Egypt’s hepatitis C elimination successes and its potential replicability in other African countries.

Action Plans and Future Initiatives

Country representatives create action plans to apply training and identify needed support from Africa CDC and Egypt. For example, Cameroon is poised to launch a Triple elimination strategy, guided by the training and support it has received.

Conclusion

Egypt Hepatitis C Program stands as a model for other African countries. Notably thanks to its comprehensive approach, innovative financing, and political commitment. The program’s achievements signal a promising pathway toward the global goal of eliminating viral hepatitis by 2030. With continued regional collaboration and strong action plans, the impact of Egypt’s efforts will undoubtedly resonate across the continent.

Reference url

Recent Posts

Strengthening Supply Chains: The EU Critical Medicines Act

By João L. Carapinha

May 12, 2026

The European Medicines Agency (EMA) has welcomed the provisional political agreement on the EU Critical Medicines Act, an initiative designed to enhance the availability, production, and supply of critical medicines throughout the European Union. This agreement represents a key a...
Marstacimab Cost-Effectiveness Analysis in Hemophilia Treatment: A Portuguese Assessment
The public assessment report for Hympavzi (marstacimab) in Portugal concludes that the product offers no added therapeutic value relative to recombinant factor VIII concentrates and emicizumab in patients aged 12 years and older weighing at least 35 kg with severe hemophilia A without factor VIII...
Overcoming Challenges in Managed Entry Agreements for ATMPs
Decision-makers in England, the Netherlands, and Spain consistently identify administrative burden, outcome measurement, and data collection as the foremost obstacles to adopting managed entry agreements ATMPs. These challenges emerge most acutely when hybrid or outcome-based agreements are consi...